Drugs / CS-ACI
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01694823 | Apr 2012 → Jul 2013 | arthritic joint disease, osteochondritis dissecans | Yan Jin | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CS-ACI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01694823 ↗ |
| Known as | Cells Sheet-Autologous Chondrocyte Implantation（ CS-ACI） | “Cells Sheet-Autologous Chondrocyte Implantation（ CS-ACI）” NCT01694823 ↗ |
| Modality | Cell therapy | “the Autologous chondrocyte implantation (ACI)technology and cell sheet technology are used to Cells Sheet-Autologous Chondrocyte Implantation(CS-ACI) for treating Cartilage Defects” NCT01694823 ↗ |